Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Declines By 45.1%

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 299,300 shares, a decline of 45.1% from the September 30th total of 544,800 shares. Based on an average daily volume of 1,700,000 shares, the short-interest ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Aethlon Medical in a research report on Wednesday, October 23rd. They set a “sell” rating on the stock.

Aethlon Medical Stock Performance

Aethlon Medical stock opened at $0.38 on Monday. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35. The firm has a market capitalization of $5.21 million, a PE ratio of -0.08 and a beta of 1.74. The business’s 50-day simple moving average is $0.41 and its 200-day simple moving average is $0.59.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same period last year, the business earned ($1.30) EPS. Research analysts forecast that Aethlon Medical will post -1.1 earnings per share for the current year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.